{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:25:27Z","timestamp":1770726327542,"version":"3.49.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Crohn\u2019s disease (CD) and ulcerative colitis (UC) are chronic inflammatory conditions of the gastrointestinal tract associated with impaired quality of life. The Communicating Needs and Features of IBD Experiences (CONFIDE) study aimed to assess the impact of CD\/UC symptoms on the lives of people with IBD and elucidate any communication gaps between healthcare professionals (HCPs) and people with IBD. The current Canadian study replicates the CONFIDE study previously conducted in the United States, Europe, and Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Online cross-sectional surveys were conducted between February and April 2023 among people with moderate-to-severe CD\/UC and prescribing HCPs. Disease severity was defined using criteria based on previous treatment, steroid use, and\/or hospitalization. Data were presented using descriptive analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Surveys were completed by 107 individuals with CD, 82 individuals with UC, and 53 HCPs. Bowel urgency was the second most common symptom reported by individuals, following diarrhoea, and it was the most frequently reported symptom leading to declining participation in work\/school, social events, and physical exercise. HCP-perceived symptoms with the greatest impact on people with IBD and their treatment decisions were diarrhoea and blood in stool. While most HCPs reported proactive discussion of bowel urgency with their patients, more than a third of those experiencing this symptom reported discussing it infrequently during HCP appointments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results indicate that CD\/UC symptoms have a substantial impact on the daily lives of people with IBD, even among those receiving advanced therapies. Although both HCPs and individuals with IBD reported a substantial symptom burden, their perceptions regarding the most impactful symptoms differed. Bowel urgency was identified as a common yet overlooked symptom and should be incorporated into regular IBD assessments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jcag\/gwaf036","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:15:35Z","timestamp":1765458935000},"page":"38-48","source":"Crossref","is-referenced-by-count":0,"title":["Communicating Needs and Features of IBD Experiences study: Canadian individuals and healthcare professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis and Crohn\u2019s disease"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-0033","authenticated-orcid":false,"given":"Vipul","family":"Jairath","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Department of Epidemiology and Biostatistics, Western University , London, ON N6A 3K7,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talat","family":"Bessissow","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, McGill University Health Centre , Montreal, QC H3G 1A4,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4747-9519","authenticated-orcid":false,"given":"Jennifer","family":"Glass","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company , Indianapolis, IN 46225,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Braun","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company , Indianapolis, IN 46225,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa Hunter","family":"Gibble","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company , Indianapolis, IN 46225,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taline","family":"Movsessian","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company , Indianapolis, IN 46225,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9417-695X","authenticated-orcid":false,"given":"Christian","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Adelphi Real World , Bollington, SK10 5JB,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Ellis","sequence":"additional","affiliation":[{"name":"Adelphi Real World , Bollington, SK10 5JB,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5453-8089","authenticated-orcid":false,"given":"Thomas","family":"Dewar","sequence":"additional","affiliation":[{"name":"Adelphi Real World , Bollington, SK10 5JB,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5247-940X","authenticated-orcid":false,"given":"Remo","family":"Panaccione","sequence":"additional","affiliation":[{"name":"University of Calgary Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, , Calgary, AB, T2N 4Z6,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"2026020910515390700_gwaf036-B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026020910515390700_gwaf036-B2","first-page":"416","article-title":"Inflammatory bowel disease: a concise review","volume":"76","author":"Hemmer","year":"2023","journal-title":"S D Med"},{"key":"2026020910515390700_gwaf036-B3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/s2468-1253(19)30173-6","article-title":"Comorbidities in inflammatory bowel disease: a call for action","volume":"4","author":"Argollo","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026020910515390700_gwaf036-B4","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/s0140-6736(16)31711-1","article-title":"Crohn\u2019s \u00addisease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"2026020910515390700_gwaf036-B5","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/s0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"2026020910515390700_gwaf036-B6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ibd\/izab192","article-title":"What is a flare? The Manitoba Living with IBD Study","volume":"28","author":"Witges","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2026020910515390700_gwaf036-B7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/21642850.2021.2007098","article-title":"Quality of life in patients with inflammatory bowel disease: the role of positive psychological factors","volume":"9","author":"Matos","year":"2021","journal-title":"Health Psychol Behav Med"},{"key":"2026020910515390700_gwaf036-B8","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1093\/jcag\/gwad004","article-title":"The 2023 impact of inflammatory bowel disease in Canada: epidemiology of IBD","volume":"6","author":"Coward","year":"2023","journal-title":"J Can Assoc Gastroenterol"},{"key":"2026020910515390700_gwaf036-B9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1155\/2012\/984575","article-title":"Inflammatory bowel disease: a Canadian burden of illness review","volume":"26","author":"Rocchi","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"2026020910515390700_gwaf036-B10","author":"Crohn\u2019s and Colitis Canada","year":"2023"},{"key":"2026020910515390700_gwaf036-B11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ibd\/izx100","article-title":"Quality of life in inflammatory bowel disease: a systematic review and meta-analyses\u2014part I","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2026020910515390700_gwaf036-B12","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1097\/meg.0000000000002178","article-title":"Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients: a prospective multicentre cohort study","volume":"33","author":"van Gennep","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026020910515390700_gwaf036-B13","doi-asserted-by":"publisher","first-page":"17562848241251600","DOI":"10.1177\/17562848241251600","article-title":"Biomarkers in inflammatory bowel disease: a practical guide","volume":"17","author":"Clough","year":"2024","journal-title":"Therap Adv Gastroenterol"},{"key":"2026020910515390700_gwaf036-B14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.dld.2016.09.009","article-title":"Patient preferences for inflammatory bowel disease treatment objectives","volume":"49","author":"Casellas","year":"2017","journal-title":"Dig Liver Dis"},{"key":"2026020910515390700_gwaf036-B15","doi-asserted-by":"publisher","first-page":"otab046","DOI":"10.1093\/crocol\/otab046","article-title":"Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn\u2019s disease in the study of a prospective adult research cohort with inflammatory bowel disease","volume":"3","author":"Dawwas","year":"2021","journal-title":"Crohn\u2019s Colitis 360"},{"key":"2026020910515390700_gwaf036-B16","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/apt.17241","article-title":"Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with IBD (the Manitoba Living with IBD Study)","volume":"56","author":"Kulyk","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026020910515390700_gwaf036-B17","first-page":"95","article-title":"Why studying urgency is urgent","volume":"19","author":"Pakpoor","year":"2023","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"2026020910515390700_gwaf036-B18","author":"Food and Drug Administration","year":"2022"},{"key":"2026020910515390700_gwaf036-B19","author":"Food and Drug Administration","year":"2022"},{"key":"2026020910515390700_gwaf036-B20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"2026020910515390700_gwaf036-B21","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1093\/ibd\/izab006","article-title":"International perspectives on management of inflammatory bowel disease: opinion differences and similarities between patients and physicians from the IBD GAPPS survey","volume":"27","author":"Rubin","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"2026020910515390700_gwaf036-B22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-230X-12-108","article-title":"Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey","volume":"12","author":"Schreiber","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"2026020910515390700_gwaf036-B23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40271-019-00407-5","article-title":"A qualitative research for defining meaningful attributes for the treatment of inflammatory bowel disease from the patient perspective","volume":"13","author":"Louis","year":"2020","journal-title":"Patient"},{"key":"2026020910515390700_gwaf036-B24","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/ibd\/izae044","article-title":"Patient perspectives of bowel urgency and bowel urgency-related accidents in \u00adulcerative colitis and Crohn\u2019s disease","volume":"30","author":"Jairath","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026020910515390700_gwaf036-B25","doi-asserted-by":"publisher","first-page":"otaa033","DOI":"10.1093\/crocol\/otaa033","article-title":"Patient\u2019s perspective on disease burden, remission definition, and symptoms associated with treatment seeking: a qualitative study in adult and adolescent patients with Crohn\u2019s disease","volume":"2","author":"Kitchen","year":"2020","journal-title":"Crohns Colitis 360"},{"key":"2026020910515390700_gwaf036-B26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/ceg.S206970","article-title":"Patient and physician preferences for ulcerative colitis treatments in the United States","volume":"12","author":"Boeri","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"2026020910515390700_gwaf036-B27","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s10620-024-08434-5","article-title":"Patient and health care professional perceptions of the experience and impact of symptoms of moderate-to-severe Crohn\u2019s disease in US and Europe: results from the cross-sectional CONFIDE study","volume":"69","author":"Schreiber","year":"2024","journal-title":"Dig Dis Sci"},{"key":"2026020910515390700_gwaf036-B28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/ibd\/izad142","article-title":"The Communicating Needs and Features of IBD Experiences (CONFIDE) study: US and European patient and health care professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis","volume":"30","author":"Travis","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"2026020910515390700_gwaf036-B29","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/s12325-024-03078-3","article-title":"Patient and health care professional perspectives on the burden and daily life impact of ulcerative colitis and Crohn\u2019s disease: results from the Japanese CONFIDE study","volume":"42","author":"Hibi","year":"2025","journal-title":"Adv Ther"},{"key":"2026020910515390700_gwaf036-B30","doi-asserted-by":"publisher","first-page":"otab050","DOI":"10.1093\/crocol\/otab050","article-title":"Novel approaches identifying relevant patient-reported outcomes in patients with inflammatory bowel diseases\u2014LISTEN 1","volume":"3","author":"Teich","year":"2021","journal-title":"Crohns Colitis 360"},{"key":"2026020910515390700_gwaf036-B31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1097\/meg.0000000000000658","article-title":"Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey","volume":"28","author":"Carpio","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026020910515390700_gwaf036-B32","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.cgh.2023.12.019","article-title":"Fecal urgency in ulcerative colitis: impact on quality of life and psychological well-being in active and inactive disease states","volume":"22","author":"Nigam","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026020910515390700_gwaf036-B33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12325-023-02726-4","article-title":"Bowel urgency in patients with ulcerative colitis and Crohn\u2019s disease: a cross-sectional real-world survey in Japan","volume":"41","author":"Wang","year":"2024","journal-title":"Adv Ther"},{"key":"2026020910515390700_gwaf036-B34","first-page":"1365","article-title":"Diagnosis and management of Crohn\u2019s disease","volume":"84","author":"Wilkins","year":"2011","journal-title":"Am Fam Physician"},{"key":"2026020910515390700_gwaf036-B35","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.14309\/ajg.0000000000002404","article-title":"Bowel urgency in ulcerative colitis: current perspectives and future directions","volume":"118","author":"Dubinsky","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"2026020910515390700_gwaf036-B36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/jir.S65979","article-title":"Inflammatory bowel disease: clinical aspects and treatments","volume":"7","author":"Fakhoury","year":"2014","journal-title":"J Inflamm Res"},{"key":"2026020910515390700_gwaf036-B37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40801-024-00434-1","article-title":"The clinical course of bowel urgency severity among patients with inflammatory bowel disease\u2014a real-world study","volume":"11","author":"Lewis","year":"2024","journal-title":"Drugs Real World Outcomes"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/9\/1\/38\/66425261\/gwaf036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/9\/1\/38\/66425261\/gwaf036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:52:01Z","timestamp":1770652321000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/9\/1\/38\/8426860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwaf036","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"value":"2515-2084","type":"print"},{"value":"2515-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,14]]}}}